• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Jefferies resumed coverage on Mettler-Toledo with a new price target

    6/3/24 8:51:01 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email
    Jefferies resumed coverage of Mettler-Toledo with a rating of Underperform and set a new price target of $1,250.00
    Get the next $MTD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    6/24/2025$1325.00Overweight
    Barclays
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    1/2/2025$1375.00 → $1450.00In-line → Outperform
    Evercore ISI
    12/13/2024Peer Perform
    Wolfe Research
    12/11/2024$1200.00 → $1300.00Sell → Neutral
    Citigroup
    More analyst ratings

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Mettler-Toledo with a new price target

      Barclays initiated coverage of Mettler-Toledo with a rating of Overweight and set a new price target of $1,325.00

      6/24/25 8:08:56 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by UBS with a new price target

      UBS upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,350.00

      5/20/25 8:01:57 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,110.00

      5/5/25 8:42:51 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Financials

    Live finance-specific insights

    See more
    • Mettler-Toledo International Inc. to Host Second Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its second quarter 2025 financial results after the market close on Thursday, July 31, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and o

      7/8/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/13/24 5:09:38 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/23 1:38:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/22 5:03:51 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    SEC Filings

    See more
    • SEC Form 11-K filed by Mettler-Toledo International Inc.

      11-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      6/27/25 1:31:53 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SD filed by Mettler-Toledo International Inc.

      SD - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/30/25 8:39:40 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/12/25 4:47:54 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      11/15/23 9:00:20 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mettler-Toledo International Inc. to Host Second Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its second quarter 2025 financial results after the market close on Thursday, July 31, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and o

      7/8/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

      Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide

      4/25/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kelly Michael A sold $1,231,846 worth of shares (1,062 units at $1,159.93) and exercised 1,062 shares at a strike of $312.36 (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/30/25 8:45:39 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Process Analytics Keller Gerry was granted 88 shares, increasing direct ownership by 1,467% to 94 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:14:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Eur & NA Market Orgs De La Guerroniere Marc was granted 186 shares (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:13:12 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    See more
    • Mettler-Toledo International Inc. Announces Change to Board of Directors

      Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021.  Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf

      11/23/22 8:00:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials